Skip to content

BV Nefromedi

Active Private limited companyfounded 2019active for 7 yearsLindelei 17, 2547 LintKBO/BCE: BE 0736.359.662

Lifetime

6 annual accounts with figures on one time axis
peak of €470,934 in 2020
€216,149▲ 1.3%
peak of €340,742 in 2020
€161,625▼ 17.1%
peak of €723,292 in 2022
€71,625▲ 616%
€94,946▼ 75.6%
Board1 name since 2019
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Dividend €100,000Equity from €10,000 to €71,625Debts from €388,700 to €94,946Cash from €151,980 to €45,761

Key points

from the 2025 annual accounts

Equity

€71,625 from €723,292 in 2022

Equity fell by 90% in 3 years.

Liquidity

1.73 was 1.02 in 2024

Short-term debts fell from €384,536 to €94,946.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 17 to 52 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as BV Nefromedi has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for BV Nefromedi. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 11-10-2019
  • 100 sharesdeed of 16-10-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0736359662
Incorporation Founding capital of €10,000, 100 shares · Founded by · appointed as director · published on 16-10-2019 · Gazette deed
First establishment Lindelei 17, Lint
All 11 events

Official details

Source: KBO
Status
Active since 14-10-2019Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 11 activities
Establishment unit
2.295.604.5722547 Lint, since 14-10-2019
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €540,000estimated
€166,571▼ 58.2%
Filing
Filed on 24-06-2026, 37 days before the end of the filing period
Financials

Insights on BV Nefromedi

BV Nefromedi files the micro format. That format states no turnover. The gross margin fell from €470,934 in 2020 to €216,149 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BV Nefromedi

What is the company number of BV Nefromedi?
The company number of BV Nefromedi is 0736.359.662. The VAT number is the same number with BE in front: BE 0736.359.662.
Where is BV Nefromedi based?
The registered office is at Lindelei 17, 2547 Lint.Company details
What does BV Nefromedi do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of BV Nefromedi?
BV Nefromedi is a private limited company (BV).
When was BV Nefromedi founded?
BV Nefromedi was founded on 14-10-2019.
Is BV Nefromedi still active?
Yes, BV Nefromedi is an active enterprise in the KBO register.
What is the turnover of BV Nefromedi?
The turnover in financial year 2025 is about €540,000. This figure is estimated from the gross margin of €216,149 and 2,452 comparable companies of the same size. It probably lies between €360,000 and €830,000. It is a rough estimate.Financials
Is BV Nefromedi profitable?
In financial year 2025, BV Nefromedi made a profit of €161,625.
Where can I find the annual accounts of BV Nefromedi?
BV Nefromedi filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BV Nefromedi due?
BV Nefromedi must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.